This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Asia Bio Partnering Forum

Early Bird Price ends in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Marina Bay Sands Convention Center
April 24—25, 2024 | SingaporeApril 29—30, 2024 | Virtual

Carl Firth
CEO at ASLAN Pharmaceuticals
Speaker

Profile

Dr Carl Firth is Chief Executive Officer of ASLAN Pharmaceuticals, a US-listed clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients.

Prior to founding ASLAN, Carl was Head of Asia Healthcare at Bank of America Merrill Lynch, supporting public and private financing of healthcare companies and advising on M&A transactions. Before joining the banking industry, Carl worked for AstraZeneca across various commercial and R&D roles, including Regional Business Development Director, Asia Pacific, and Director of New Product Development, China.

Carl holds board positions at various biotechs, including JAGUAHR Therapeutics and DotBio. Previously, Carl served as an independent director of A*ccelerate, the commercialisation arm of Singapore's Agency for Science, Technology and Research (A*STAR), an independent director of Hong Kong listed Uni-Bio Sciences, a commercial stage Chinese pharmaceutical company, and was a member of Singapore's Health and Biomedical Sciences International Advisory Council.

Carl is an Adjunct Professor at Duke-NUS Medical School. He has a PhD in Molecular Biology from Cambridge University (Trinity College), an Executive MBA from London Business School; and a BA in Molecular Biology from Cambridge University. Carl is also the Founder of Pink Lions, a group for LGBTQ+ professionals working in healthcare and life sciences in Singapore.

Agenda Sessions

  • Biotech IPO landscape in Asian markets: latest trends, predictions, and emerging ways to raise funds

    1:30pm

At this event